Acadian Asset Management’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Acadian Asset Management’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,746	Closed	-$103K	–	2084
2021 Q2	$103K	Buy	3,746 +770	+26%	+$19.7K	﹤0.01%	1628
2021 Q1	$82K	Buy	+2,976	New	+$90.3K	﹤0.01%	1721
2020 Q1	–	Sell	-1,039	Closed	-$35K	–	1971
2019 Q4	$35K	Sell	1,039 -269	-21%	-$7.78K	﹤0.01%	1656
2019 Q3	$34K	Hold	1,308	–	–	﹤0.01%	1667
2019 Q2	$43K	Buy	1,308 +1,039	+386%	+$60.7K	﹤0.01%	1502
2019 Q1	$24K	Buy	+269	New	+$22.3K	﹤0.01%	1792

Other funds holding NURO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Acadian Asset Management's NURO Position: Q3 2021 in Review

Acadian Asset Management sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q3 2021, closing a stake of 3,746 shares — an estimated $103K sold.

Acadian Asset Management first reported a position in NURO in Q1 2019 and held it in 6 quarters. The position peaked at $103K in Q2 2021. 21 funds tracked by Wall St. Rank hold NURO as of Q3 2021.

Acadian Asset Management reported no remaining NeuroMetrix, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Acadian Asset Management sold 3,746 NeuroMetrix, Inc. Common Stock shares in Q3 2021, an estimated $103K.
Acadian Asset Management first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
Acadian Asset Management's NeuroMetrix, Inc. Common Stock position peaked at $103K in Q2 2021.
21 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.